Capital Advisors Ltd’s DarioHealth DRIO Stock Holding History

Capital Advisors Ltd’s Portfolio DRIO Stock Details DRIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-2	Closed	–	–	1298
2022 Q2	$0	Buy	+2	New	+$235	﹤0.01%	1071

Other funds holding DRIO

NCM

Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return

Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return

Phoenix Financial Givatayim, Israel $10.5B AUM 49.21% 1-Year Est. Return

AWAM

Appian Way Asset Management New York $558M AUM 1.95% 1-Year Est. Return

MCM

MAI Capital Management Independence, Ohio $17.7B AUM 18.87% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Capital Advisors Ltd's DRIO Position: Q3 2022 in Review

Capital Advisors Ltd sold out of DarioHealth (DRIO) in Q3 2022, closing a stake of 2 shares.

Capital Advisors Ltd first reported a position in DRIO in Q2 2022 and held it in 1 quarter. The position peaked at $0 in Q2 2022. 45 funds tracked by Wall St. Rank hold DRIO as of Q3 2022.

Capital Advisors Ltd reported no remaining DarioHealth position as of Q3 2022 after selling out during the quarter.
Capital Advisors Ltd sold 2 DarioHealth shares in Q3 2022.
Capital Advisors Ltd first reported a position in DarioHealth in Q2 2022 and held it in 1 quarter.
Capital Advisors Ltd's DarioHealth position peaked at $0 in Q2 2022.
45 funds tracked by Wall St. Rank held DarioHealth as of Q3 2022.

Based on Capital Advisors Ltd's 13F filing for Q3 2022, filed 9 Nov 2022.